Shamburg News · 8-K filed Oct 7, 2026, 8:01 AM EDT
Azenta Approves Multiomics Restructuring Plan With $11.0M-$13.0M Pre-Tax Charges
AZTA · Azenta, Inc.
- Other event
- Other
- Materiality: medium
On October 5, 2026, Azenta's Board approved a restructuring plan within its Multiomics segment involving workforce reductions and closure of three North American laboratory sites. The company estimates aggregate pre-tax charges of approximately $11.0 million to $13.0 million, including about $9.0 million of asset impairment charges, and expects approximately $11.0 million of annualized cost savings. The company expects to recognize substantially all charges in the fiscal year ending September 30, 2027, and to substantially complete the actions by March 31, 2027.
Source: SEC EDGAR, Form 8-K, Items 2.05, 2.06, 9.01, accession 0001628280-26-065292.
Written from the filing by Shamburg Markets. Figures are as reported by the company.